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i.org/1(MI). Primary percutaneous coronary intervention (PCI) has markedly reduced myocardial
damage of the left ventricle, but reliable data on RV damage using cardiac magnetic resonance
imaging (MRI) are scarce. In a recent trial of patients with acute MI treated with primary PCI,
in which the primary end point was left ventricular (LV) ejection fraction after 4 months
measured withMRI, we conducted a prospectively deﬁned substudy in which we examined RV
function. RV ejection fraction (RVEF) and RV scar size were measured with MRI at 4 months.
Tricuspid annular plane systolic excursion (TAPSE) and RV free wall longitudinal strain
(FWLS) were assessed using echocardiography before discharge and at 4 months. We studied
258 patients without diabetes mellitus; their mean age was 58 – 11 years, 79% men and mean
LV ejection fraction was 54 – 8%. Before discharge, 5.2% of patients had TAPSE <17mm, 32%
had FWLS >L20% and 11% had FWLS >L15%. During 4 months, TAPSE increased from
22.8 – 3.6 to 25.1 – 3.9 mm (p <0.001) and FWLS increased fromL22.6 – 5.8 toL25.9 – 4.7%
(p <0.001). After 4months,meanRVEF onMRIwas 64.1 – 5.2% andRV scarwas detected in 5
patients (2%). There was no correlation between LV scar size and RVEF (p [ 0.9), TAPSE
(p[ 0.1), or RV FWLS (p[ 0.9). In conclusion, RV dysfunction is reversible in most patients
and permanent RV ischemic injury is very uncommon 4 months after acute MI treated with
primary PCI.  2016 The Authors. Published by Elsevier Inc. This is an open access article
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). (Am J
Cardiol 2016;118:338e344)Right ventricular (RV) dysfunction is a powerful pre-
dictor of outcome after acute myocardial infarction (MI).1,2
Most studies on RV injury after acute MI was performed in
the thrombolysis era.3 Despite the current large-scale use of
primary percutaneous coronary intervention (PCI), RV
dysfunction after acute MI remains common and associated
with worse prognosis.4e9 In most studies, results are based
on conventional echocardiography early after MI, whereas
the RV frequently recovers from ischemic injury in the post-f aCardiology, cRadiology, and dCritical Care, University
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0.1016/j.amjcard.2016.05.006MI period.10,11 In the current era of primary PCI, the degree
of left ventricular (LV) damage is increasingly limited. In a
recent study on the potential value of metformin in acute
MI, it was demonstrated that mean left ventricular ejection
fraction (LVEF) on magnetic resonance imaging (MRI)
4 months after PCI was 54%.12 Any effects on RV func-
tional parameters of this early intervention, in such cohort of
patients with large myocardial areas at risk, were not re-
ported. Since the RV is relatively protected against ischemic
injury, we hypothesize that RV systolic function remains
preserved after early PCI. In the present study, we therefore
aimed to evaluate RV function after acute MI treated with
PCI using both MRI and echocardiography.
Methods
The design and results of the Glycometabolic Interven-
tion as Adjunct to Primary Percutaneous Coronary Inter-
vention in ST-Segment Elevation Myocardial Infarction
(GIPS) III trial have been published previously.12,13 In brief,
the GIPS-III was a prospective, double-blind, randomized
placebo-controlled trial, in patients who underwent primary
PCI for ST-segment elevation MI (STEMI). The trial wasccess article
4.0/).
www.ajconline.org
Figure 1. Flow of patients included in the present study. In case of multiple
reasons for exclusion, only the primary reason of each case is shown.
CABG ¼ coronary artery bypass grafting; ICD ¼ implantable
cardioverteredeﬁbrillator.
Coronary Artery Disease/RV Function After Acute Myocardial Infarction 339designed to study the effect of metformin. All patients had
an electrocardiographic recording with ST-segment eleva-
tion of more than 0.1 mV in 2 or more leads and were
treated with at least 1 stent sized 3.0 mm. Major exclusion
criteria were: previous MI, diabetes, and need for coronary
artery bypass grafting. In the GIPS-III clinical trial, 380
patients were randomized 1:1 to receive metformin or pla-
cebo. The primary efﬁcacy measure was LVEF measured by
MRI 4 months after PCI. The GIPS-III trial demonstrated no
signiﬁcant difference in LVEF. All patients underwent
additional echocardiographic assessment before discharge
and 4 months. The study complies with the Declaration of
Helsinki and was approved by the local ethics committee
(Groningen, the Netherlands). All patients included in the
GIPS-III trial provided written informed consent.
MRI studies were performed on 3.0-T scanner (Achieva,
Philips, Best, The Netherlands). Electrocardiogram-gated
cine steady state, free precession images were acquired
with breath holding in contiguous short-axis slices covering
the entire RV and LV (TR 3.9 ms; TE 1.94 ms; ﬂip angle
45; matrix 180  220; voxel sixe 1.25  1.25  10 mm;
slice thickness 10 mm; and slice gap 0 mm). Using identical
slice locations, late gadolinium enhancement (LGE) images
were acquired 10 minutes after intravenous administration
of a gadolinium-based contrast agent (Dotarem, Gorinchem,
the Netherlands; 0.2 mmol/kg) with an inversion recovery,
gradient echo pulse sequence to identify the location and
extent of MI. The inversion time was individually set to null
the signal of viable myocardium (TR 5.2 ms; TE 2.5 ms; ﬂip
angle 5; matrix 192  157; voxel sixe 1.25  1.25 
10 mm; slice thickness 10 mm; and slice gap 0 mm).
RV volumetric measurements were performed by a sin-
gle experienced observer (TMG), blinded for medical his-
tory and treatment allocation. The endocardial and
epicardial contours of the RV were traced manually on all
end-systolic and end-diastolic slices, using QMass 7.6
(Medis, Leiden, the Netherlands). On the most basal slice,
the right atrium and the pulmonary artery were excluded.
Papillary muscle and trabeculae were included in the RV
blood volume. RV end-systolic and end-diastolic volumes,
stroke volume, ejection fraction (RVEF), and mass were
calculated. The presence of RV LGE was visually deter-
mined by 2 independent observers, blinded for medical
history and treatment allocation (TMG and TPW) and
reviewed by a third observer (RN). RV LGE size was ob-
tained by manually drawing regions of interest, using
QMass 7.6 (Medis, Leiden, the Netherlands), and expressed
as percentage of RV mass. An independent core laboratory
(Image Analysis Center, VU University Medical Center,
Amsterdam, the Netherlands) analyzed volumetric and LGE
measurements of the LV.12 RVEF and RV end-diastolic
volumes, indexed for body surface area were compared
with normal reference values (i.e., males: RVEF 48% and
indexed RV end-diastolic volume [RVEDVi] 114 ml/m2;
females: RVEF 50% and RVEDVi 103 ml/m2).14 Body
surface area was calculated using the simpliﬁed calculation
of Mosteller.15
All echocardiographic images were acquired using
Vivid 7 and E9 systems (General Electric, Horton, Nor-
way) with a 2.5- to 3.5-mHz probe and were digitally
stored. Tricuspid annular plane systolic excursion(TAPSE) was obtained with M-mode parallel to the RV
free wall and across the tricuspid annular plane and
TAPSE <17 mm was deﬁned abnormal.16 The longitu-
dinal systolic movement of the lateral RV annulus was
measured. RV free wall longitudinal strain (FWLS) was
analyzed on the standard apical 4-chamber view using
2-dimensional (2-D) speckle tracking software by 2 in-
vestigators (TMG and YMH) using GE EchoPAC version
BT12. Echocardiographic images with poor quality or
poor tracking of 2 or more RV wall segments were
excluded from the analysis. The endocardial border of the
RV wall was manually traced according to current rec-
ommendations.16 On the most basal part, sampling of the
right atrium, tricuspid annulus, and pericardium was
avoided. RV FWLS was calculated as the mean of basal,
mid, and apical segments of the RV free wall
(Supplementary Data). RV FWLS > 20% is suggested
moderately reduced and > 15% severely reduced.17
Intraobserver and interobserver reliability for RV FWLS
measurements was assessed using 30 randomly selected
studies.
Data were reported as mean  SD for normally distrib-
uted data, median (interquartile range) for skewed distrib-
uted data or n (%) for categorical variables. Differences in
continuous variables between subgroups were assessed us-
ing independent samples t tests, ManneWhitney U tests or
one-way analysis of variance, according to distribution and
the level of subgroups. Differences in categorical variables
between groups were performed using chi-square tests.
Change in RV FWLS during the 4 months was compared
using paired samples t tests. Correlations between contin-
uous variables were performed using Pearson’s correlation.
Intraobserver and interobserver variability of RV FWLS
Table 1
Baseline characteristics of the total study population
All patients
(n¼258)
Metformin
(n¼129)
Placebo
(n¼129)
Age (years) 57.6  11.4 57.5  11.4 57.7  11.4
Men 203 (79%) 102 (79%) 101 (78%)
Body mass index (kg/m2) 27.0  3.5 26.9  3.7 27.0  3.3
Hypertension 72 (28%) 40 (31%) 32 (25%)
Dyslipidemia 165 (64%) 77 (60%) 88 (68%)
Current smoker 130 (50%) 69 (54%) 61 (47%)
Stroke 1 (0.4%) 1 (0.8%) 0
Peripheral artery disease 0
Previous PCI 4 (1.6%) 1 (0.8%) 3 (2.3%)
Clinical presentation
Systolic blood pressure (mm Hg) 133  22 133  21 132  23
Diastolic blood pressure (mm Hg) 84  15 85  15 83  15
Heart rate (beats/min) 76  16 76  15 76  17
Total ischemic time (min) 156 (105 e 243) 163 (109 e 265) 146 (102 e 232)
Single-vessel coronary disease 187 (73%) 89 (69%) 98 (76%)
Infarct-related coronary artery
Left main coronary artery 0
Left anterior descending 106 (41%) 52 (40%) 54 (42%)
Proximal 70 (27%) 32 (25%) 38 (30%)
Mid 32 (12%) 17 (13%) 15 (12%)
Left circumﬂex artery 43 (17%) 21 (16%) 22 (17%)
Right coronary artery 109 (42%) 56 (43%) 53 (41%)
Proximal 37 (14%) 15 (12%) 22 (17%)
Mid 48 (19%) 28 (22%) 20 (16%)
Infarct-related artery TIMI ﬂow
Pre intervention grade
0 148 (57%) 71 (55%) 77 (60%)
1 18 (7%) 9 (7%) 9 (7%)
2 44 (17%) 27 (21%) 17 (13%)
3 48 (19%) 22 (17%) 26 (20%)
Post intervention grade
2 16 (6%) 10 (8%) 6 (6%)
3 242 (94%) 119 (92%) 123 (95%)
Myocardial blush grade
0 4 (2%) 1 (1%) 3 (2%)
1 18 (7%) 11 (9%) 7 (5%)
2 56 (22%) 27 (22%) 29 (23%)
3 178 (69%) 88 (68%) 90 (70%)
Laboratory values at admission
Creatine kinase (U/L) 133 (90 e 215) 143 (97 e 285) 123 (87 e 181)
Myocardial band of creatine kinase (U/L) 17 (13 e 25) 18 (14 e 34) 16 (13 e 23)
Creatinine (mmol/L) 72 (64 e 82) 71 (62 e 85) 73 (64 e 80)
NT-proBNP (ng/L) 79 (38 e 180) 80 (41 e 218) 78 (37 e 118)
Glucose (mmol/L) 8.2 (6.9 e 9.4) 8.3 (6.9 e 9.5) 8.1 (6.9 e 9.3)
HbA1c (%) 5.8 (5.6 e 6.0) 5.7 (5.6 e 6.0) 5.8 (5.6 e 6.0)
Variables are expressed as n (%), mean  SD or median (interquartile range).
340 The American Journal of Cardiology (www.ajconline.org)was assessed using 2-way mixed intraclass correlation co-
efﬁcient. Statistical signiﬁcance was considered achieved
with a p value <0.05. Statistical analyses were performed
using SPSS statistical software for Windows (version 20,
2011).
Results
In total, 380 patients were randomized in the GIPS-III
trial, and a total of 258 patients were included in the pre-
sent study (Figure 1). In a large subset of patients, sufﬁcient
echocardiographic imaging was available both beforedischarge and at 4 months. Baseline characteristics of the
study population are outlined in Table 1.
Table 2 summarizes RV and LV function on MRI at
4 months. No patient had reduced RVEF. RVEF was not
different according to culprit lesion (i.e., left anterior
descending coronary artery [LAD], right coronary artery
[RCA], and left circumﬂex coronary artery [LCX]; p ¼ 0.11).
There was no difference in RVEF between patients with LV
LGE septal involvement (n ¼ 171) and without septal
involvement (n¼ 72); p¼ 0.43. RVEF was higher in women
compared with men (67% vs 63%, p <0.001). Age was
weakly correlated with RVEF (r ¼ 0.15, p ¼ 0.02). RVEF
Table 3
Right ventricular late enhancement after 4 months
Subject Sex/age
(yrs)
Right
coronary
artery
RV scar size LV
scar size
Location
1 M/45 Mid 1.3% 7.0% Inferoseptal
2 M/53 Mid 13.2% 6.5% Inferolateral
3 M/81 Proximal 7.0% 8.9% Inferoseptal
4 M/63 Mid 11.4% 20.6% Inferoseptal
5 F/68 Proximal 4.1% 13.2% Inferoseptal
Table 2
Right and left ventricular volumes and function
MRI after 4 months
RV end-diastolic volume (ml) 159  36
RV end-systolic volume (ml) 58  18
RV ejection fraction (%) 64  5
RV infarct size (%, n¼5) 7.4  4.9
LV end-diastolic volume (ml) 193  44
LV end-systolic volume (ml) 90  33
LV ejection fraction (%) 54  8
LV infarct size (%, n¼243) 8.9  7.6
Echocardiography before discharge
Tricuspid annular plane systolic excursion (mm) 22.8  3.6
RV free wall longitudinal strain (%) -22.6  5.8
Echocardiography after 4 months
Tricuspid annular plane systolic excursion (mm) 25.1  3.9*
RV free wall longitudinal strain (%) -25.9 4.7*
Variables are expressed as mean  standard deviation.
* p <0.001 compared with value before discharge.
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(p¼ 0.24). LVEF was fairly correlated with RVEF (r¼ 0.25,
p <0.001); LV end-diastolic volume index did not correlate
with RVEF (r¼ 0.04, p¼ 0.55) and also LV scare size was
not associated with RVEF (r ¼ 0.01, p ¼ 0.91). There was
a slight difference in RVEF between the metformin andFigure 2. Inferior infarction in a 68-year-old woman with proximal RCA occlusi
enhancement in the inferior and inferoseptal segments of the left ventricle and a s
extents into the inferior segment of the right ventricle (white arrow). In this subjec
PCI (i.e., LVEF 53% and RVEF 68%). Echocardiographic quality was insufﬁcieplacebo group (63% vs 65%, p ¼ 0.03). After adjustment for
age, gender and LVEF, this difference did not remain sig-
niﬁcant (p ¼ 0.11). Indexed RVEDVis above normal refer-
ence values were seen in 2 patients (0.8%). RVEDVi was
higher in men compared with women (80 vs 70 ml/m2,
p <0.001) and was fairly correlated with age (r ¼ 0.27,
p<0.001). RV LGE was detected in 5 patients (2%; Table 3).
All RV infarctions were not isolated but extended throughout
the inferior wall. Figure 2 is an example of such patient.
Table 2 depicts echocardiographic measurements of RV
function. Before discharge, 1.6 (interquartile range 1.4 to
2.5) days after STEMI, 12 patients (5.2%) had reduced
TAPSE. TAPSE values were the same among culprit vessel
(i.e., RCA vs LAD, p ¼ 0.40 and RCA vs LCX, p ¼ 0.17).
Before discharge, 46 patients (32%) had RV FWLS
> 20% and 15 patients (11%) had RV FWLS > 15%.
RV FWLS was lower with RCA (20.6%) than with culprit
LAD (23.6%, p ¼ 0.007) or LCX (24.9%, p ¼ 0.002).
TAPSE and RV FWLS increased signiﬁcantly during
4 months (Figure 3). Increase in TAPSE was the same for all
culprit vessels (Figure 3). Increase in RV FWLS was more
pronounced with culprit RCA (from 20.6% to 24.9%, p
<0.001) and LAD (from 23.6% to 26.9%, p <0.001)
than in patients with culprit LCX (from 24.9% to 26.0%,
p ¼ 0.33; Figure 3).
After 4 months, 1 patient (0.4%) had reduced TAPSE, 14
patients (10%) had RV FWLS > 20%, and 2 patients
(1.4%) had RV FWLS > 15%. RV FWLS was signiﬁ-
cantly lower with RCA than with LAD lesions (24.8%
vs 26.9%, respectively; p ¼ 0.02). There was no signiﬁ-
cant difference in RV FWLS between culprit RCA and LCX
(24.8 vs 26.0, respectively; p ¼ 0.21). There was no
difference in TAPSE and RV FWLS at 4 months between
patients with LGE septal involvement and without septal
involvement; p ¼ 0.89 and 0.98, respectively. TAPSE was
weakly correlated with LVEF (r ¼ 0.15, p ¼ 0.02) but not
with LV infarct size (p ¼ 0.18). RV FWLS was not corre-
lated with LVEF (r ¼ 0.07, p ¼ 0.44) nor LV infarct size
(r ¼ 0.03, p ¼ 0.71). There was no signiﬁcant difference inon. Short-axis LGE imaging 4 months after PCI shows subendocardial late
mall region of microvascular obstruction (black arrows). Late enhancement
t, both left and right ventricular function remained preserved 4 months after
nt for additional strain analyses.
Figure 3. Change in right ventricular function after acute MI. (A): TAPSE
measured before discharge (T0) increased during 4 months (T1) after acute
myocardial infarction in all patients. This increase was demonstrated in all
subgroups with culprit RCA (p <0.001), LAD (p <0.001), and LCX (p ¼
0.032). (B): RV FWLS measured before discharge (T0) increased during
4 months (T1) after acute MI in all patients. This increase was more pro-
nounced in patients with culprit RCA (p <0.001) and LAD (p <0.001),
than with culprit LCX (p ¼ 0.33). Patients with culprit RCA had the lowest
RV FWLS early and late after the infarction.
342 The American Journal of Cardiology (www.ajconline.org)TAPSE and RV FWLS between both treatment groups (p ¼
0.96 and 0.94, respectively).
Intraclass correlation for intraobserver variability for RV
FWLS longitudinal strain was 0.70 (95% CI 0.46 to 0.84, p
<0.001). For the interobserver measurements, the correla-
tion for RV FWLS longitudinal strain was 0.76 (95% CI
0.72 to 0.94, p <0.001).
Discussion
This study demonstrated that early after primary PCI for
STEMI, RV function was reduced in several patients. Yet,
the RV recovered in most patients, and permanent ischemic
damage of RV myocardium at 4 months was very uncom-
mon. LV ischemic injury had almost no impact on RV
global and regional function.In contrast to the LV, the vulnerability of the RV to
ischemic and reperfusion stimuli is different. In normal
physiologic conditions, myocardial oxygen demand of the
RV is lower than for the LV, due to lower vascular resis-
tance in the pulmonary compared with the systemic circu-
lation. In addition, because of the thinner free wall and less
intracavitary pressure, the RV receives transmural and direct
endocardial perfusion in both systole and diastole.18e20
Therefore, RV myocardium in the absence of coronary
ﬂow still receives a marginal amount of oxygen and nutri-
ents, resulting in “stunning” rather than cell death.10,11
More recently, Masci et al21 yield new insights in this
myocardial stunning pattern. RV ischemic injury was
reversible in 20% of cases and permanent RV myocardial
damage at 4 months after STEMI was demonstrated in 10%.
Our study showed an even lower incidence of irreversible
damage late after STEMI. As can be expected with this low
percentage of RV damage, no RV dysfunction in terms of
RVEF and TAPSE was seen. Although MRI is the gold
standard RV function, RVEF is a rather gross, volumetric
measure. Although MRI derived myocardial strain is useful
in assessing regional myocardial function of the LV,22 RV
myocardium is often too thin for reliable measurements. In
addition, TAPSE is an angle-dependent measurement and
only represents longitudinal displacement of the tricuspid
annulus. In contrast, 2-D strain echocardiography has
demonstrated its value to detect subtle RV myocardial
dysfunction in various cardiac diseases.23,24 Recently, RV
global longitudinal strain (GLS) was suggested to be a
strong indicator of RV systolic function and prognosis after
PCI for acute MI.7 However, these echocardiographic as-
sessments were performed within 3 days after PCI, after
which the stunning RV may well recover. Furthermore, for
RV GLS, the investigators averaged RV free wall and
interventricular septal longitudinal strain measurements.
Since GLS is intentionally designed for the LV, and RV
geometry and contraction pattern are distinctively different,
in our opinion, this method cannot be easily adopted to the
RV. In the present study, RV function recovered during
4 months after the PCI. This stunning pattern was most
pronounced in patients with culprit RCA and LAD,
compared with LCX, in whom no post-MI RV dysfunction
was observed. This observation is not unexpected because
the RV is frequently involved in left-sided anterior and
inferior infarctions,25,26 and LAD occlusion often results in
apical inferior injury, which may affect the RV.27
How do we explain the absence of permanent RV injury
in the current cohort with large myocardial areas at risk,
compared with previous studies? The principle of “time is
muscle” has led to the critical threshold of <90 minutes
door-to-balloon time for primary PCI.28,29 However,
symptom-to-balloon time may vary considerably, for
instance due to differences in patient awareness or delay in
emergency response. Total ischemic times varied between
211 and 297 minutes in previous studies investigating RV
injury in STEMI,7,9,21 which is considerably lower than our
156 minutes. This is similar with previously published data
of patients with STEMI in the Netherlands30 and may be the
result of several factors, including favorable geographic
conditions and well organized multidisciplinary STEMI
health care.30 Early successful, primary PCI for STEMI, in a
Coronary Artery Disease/RV Function After Acute Myocardial Infarction 343dedicated center, might therefore prevent permanent RV
ischemic injury in acute MI. However, observed differences
in prevalence rates of RV dysfunction might also be
attributable to variations in method and patient characteris-
tics among studies investigating RV function after acute MI.
Some limitations merit emphasis. First, serial MRI data
were lacking in this study; hence, we were not able to
evaluate RV LGE early after the infarction. However,
TAPSE and RV FWLS assessed before discharge was used
as surrogate measure of RV involvement at baseline. Sec-
ond, as 2-D strain analysis is largely dependent on image
quality, RV FWLS could not be assessed in all patients and
also no deﬁnite cutoffs for RV FWLS are currently avail-
able. Finally, we may have introduced a selection bias since
only nondiabetic patients without previous MI or revascu-
larization were included.
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